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Abstract
Aim: To assess serum testosterone and gonadotropins in Sertoli cell only syndrome patients from Gaza
Strip.
Methods: Based on testicular biopsy, a cross section of 74 Sertoli cell only syndrome patients were enrolled
in the study.  Age matched 44 fertile men were served as controls. Patients and controls were questioned
for their medical history. Blood samples were drawn and serum testosterone, luteinizing hormone (LH),
and follicle stimulating hormone (FSH) were determined by enzyme-linked immunosorbent assay. Data
were computer analyzed using SPSS/PC, version 18.0.
Results: Varicocele and hormonal problems were significantly more frequent among patients than controls
(P<0.05). Serum testosterone was significantly lower in patients compared to controls (1.7±1.3 versus
5.0±2.2 ng/ml, P=0.000). In contrast, LH and FSH were significantly higher in patients than controls (12.8±9.7
and 20.8±14.8 mlU/ml versus 6.3±3.1 and 7.7±3.9 mlU/ml, P=0.000, respectively). Hypergonadotrophic
hypogonadism and hypogonadotrophic hypogonadism patients showed lower levels of testosterone
compared to the normal reference value (0.9±0.5 and 0.5±0.4 ng/ml versus 2.0-7.0 ng/ml). Higher levels of
LH and FSH were recorded in hypergonadotrophic hypogonadism (24.5±2.6 and 37.4±6.7 mlU/ml) compared
to the reference values of 2.0-13.0 and 2.5-10.0 mlU/ml, respectively whereas LH and FSH levels were
lower in hypogonadotrophic hypogonadism (0.6±0.4 and 0.6±0.5 mlU/ml, respectively). In this context, all
hypergonadotrophic hypogonadism and hypogonadotrophic hypogonadism patients showed abnormal levels
of testosterone, LH and FSH.
Conclusions: Abnormal levels of serum testosterone, LH and FSH, particularly in hypergonadotrophic
hypogonadism and hypogonadotrophic hypogonadism were identified in infertile men with Sertoli cell only
syndrome from Gaza Strip.
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Introduction
One of the important issues contributing to male infertility
is azoospermia which is defined as the absence of sperm in
at least two different ejaculate samples, including the
centrifuged sediment.1 The etiology of azoospermia may be
attributed to 1) pre-testicular causes e.g. endocrine
abnormalities causing secondary testicular failure, 2)
testicular causes e.g. primary testicular failure due to intrinsic
disorders of spermatogenesis within the testis, including
maturation arrest and complete absence of germ cells or
Sertoli cell only syndrome or 3) post testicular causes e.g.
ejaculatory dysfunction or ductal obstruction that prevent
sperm transport.2
Sertoli cell only syndrome or germ cell aplasia is one of the
etiologic categories of non-obstructive azoospermia that
applies to a testicle in which germ cells at any stage of
maturation are absent, but the tubular architecture is not
effaced by fibrosis and supporting cells continue to be
present.3 Examples of causes of Sertoli cell only syndrome
may include genetic factors, hormonal factors, idiopathic
factors, varicocele, toxin exposure, history of radiation
therapy, and history of severe trauma.4-6
Endocrine malfunctions are more prevalent in infertile men
than in the general population, but still quite uncommon.
Abnormalities of the hypothalamic-pituitary-testicular axis
at the testicular level cause primary testicular failure, whereas
central defects of the hypothalamus or pituitary cause
secondary testicular failure. Hypergonadotropic
hypogonadism results in low testosterone levels, impairment
of spermatogenesis and elevated gonadotropin levels.
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Hypogonadotropic hypogonadism results in low testosterone
levels, impairment of spermatogenesis and low or low-
normal gonadotropin levels.7,8
Research carried out on azoospermia in Gaza strip is very
limited. To our knowledge, only two recent studies published;
one addressed screening for Y chromosome microdeletions
in a population of infertile males9 and the other study handled
hormonal and histological aspects among infertile men in
Gaza strip.10 However, the present study focused specifically
on testosterone and gonadotropin hormones in infertile men
with Sertoli cell only syndrome from Gaza Strip. Therefore,
the present study provided more information on endocrine
profile of Sertoli cell only syndrome and highlighted an
extraordinary public health problem of high concern for
couples seeking children in Gaza Strip.
Subjects and Methodology
Subjects
Based on testicular biopsy, a cross section of 74 infertile
men with Sertoli cell only syndrome (patients) visiting the
Specialized Medical Centers in Gaza strip were enrolled in
the present study. They have the history of at least 3 years
duration of infertility.11 Semen analysis was also performed
to confirm azoospermia based on World Health Organization
criteria.1 A total number of 44 controls were selected at the
basis of being married with at least one child and sperm
count >20 million sperm/ml. Patients and controls were age
matched. Ethical approval was provided by Helsinki
committee at the Palestinian Ministry of Health and all
participants gave an informed consent. Patients and controls
were questioned for their medical history.
Testicular biopsy
Incision biopsy was taken by physician, from bilateral testes,
then pre solved in Bouin’s solution as a fixative reagent.12
Following fixation, dehydration of fixed tissues was done
through ascending grades of ethyl alcohol (50%, 70%, 90%,
95% and absolute alcohol). Tissues were then cleared with
xylene. This was followed by impregnation with paraffin
wax. Having been completely impregnated, the tissues were
embedded in paraffin wax, sectioned by a rotary microtome
at a thickness of 3 ¼m, mounted and affixed to slides.
Sections were then stained as a routine in harris’s alum
haematoxylin and eosin.
Blood sampling and processing
Venous blood samples were drawn by a well-trained medical
technologist into vacutainer tubes from patients and controls.
Blood was left for a while without anticoagulant to allow
blood to clot. Then, serum samples were obtained by
centrifugation at room temperature at 3000 rpm/10 minutes
for hormonal assay. Testosterone, LH and FSH levels were
determined by enzyme-linked immunosorbent assay, TECO
kit, USA.
Statistical analysis
Data were computer analyzed using SPSS/PC (Statistical
Package for the Social Science Inc. Chicago, Illinois USA,
version 18.0) statistical package. Simple distribution of the
study variables and the cross tabulation were applied. Yates’s
continuity correction test, χ2 (corrected), was used as not more
than 20% of the cells had an expected frequency of less than
five and the expected numbers were small. The independent
sample t-test procedure was used to compare means of
quantitative variables by the separated cases into two
qualitative groups such as the relationship between patients
and controls hormones. Percent difference = ( | (V1 - V2) | /
((V1 + V2)/2) ) * 100. The one-way ANOVA test was applied.
The results were accepted as statistical significant when the
p-value was less than 5% (P<0.05).
Results
Medical history of the study population
The mean age of patients (n=74) and controls (n=44) were
29.8±5.9 and 30.2±5.7 years, respectively. Medical history
revealed that varicocele was significantly more prevalent
among patients compared to controls 12 (16.2%) versus 1
(2.3%), χ2 (corrected)=4.142 and P=0.042. Similarly, hormonal
problems were significantly higher in patients than controls
19 (25.7%) versus 2 (4.5%), χ2 (corrected)=7.039 and P=0.008.
Although trauma was more frequent among patients, the
difference between patients and controls was not significant
9 (12.2%) versus 2 (4.5%), χ2 (corrected)=1.120 and P=0.294.
Testosterone and gonadotropins levels of the study
population
As illustrated in Table I, the mean level of testosterone was
significantly lower in patients compared to controls with
percentage difference of 98.5% (1.7±1.3 versus 5.0±2.2 ng/
ml, t=10.054, P=0.000). In contrast, the mean levels of LH
and FSH were significantly higher in patients compared to
controls showing percentage differences of 68.1% and
91.9%, respectively (12.8±9.7 and 20.8±14.8 mlU/ml versus
6.3±3.1 and 7.7±3.9 mlU/ml, t=4.352 and t=5.708, P=0.000,
respectively).
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Testosterone and gonadotropins of different aspects of Sertoli
cell only patients
As indicated in Table II, ANOVA test showed significant
change among different diagnostic aspects of Sertoli cell
only syndrome for each particular hormone (P=0.000).
Lower levels of testosterone were found in
hypergonadotrophic hypogonadism and hypogonadotrophic
hypogonadism compared to the normal reference value
(0.9±0.5 and 0.5±0.4 versus 2.0-7.0 ng/ml). In primary
testicular failure and idiopathy testosterone levels were in
the range of normal reference value. Higher levels of LH
and FSH were recorded in primary testicular failure
(17.3±6.1 and 28.9±6.3 mlU/ml, respectively) as well as in
hypergonadotrophic hypogonadism (24.5±2.6 and 37.4±6.7
mlU/ml, respectively) compared to the reference values of
2.0-13.0 and 2.5-10.0 mlU/ml, respectively. In contrast, LH
and FSH levels were lower in hypogonadotrophic
hypogonadism (0.6±0.4 and 0.6±0.5 mlU/ml, respectively).
In idiopathy, LH and FSH levels were in the range of normal
reference values.
Normal and abnormal testosterone and gonadotropins levels
of different aspects of Sertoli cell only patients
As indicated in Table III, the number of primary testicular
failure, hypergonadotrophic hypogonadism, hypogon-
adotrophic hypogonadism and idiopathic patients showing
abnormal levels of testosterone were 18 (45.0%), 9 (100%),
14 (100%) and 3 (27.3%), respectively compared to 22
(55.0%), 0 (0.0%), 0 (0.0%) and 8 (72.7%) patients with
normal levels of the hormone (χ2 (corrected)=18.890 and
P=0.000). Abnormal levels of LH were exhibited by 30
(75.0%), 9 (100%) and 14 (100%) and 4 (36.4%) patients,
respectively versus 10 (25.0%), 0 (0.0%), 0 (0.0%) and 7
(63.6%) patients with normal levels (χ2 (corrected)=12.644 and
P=0.005). For FSH, all primary testicular failure,
hypergonadotrophic hypogonadism, hypogonadotrophic
hypogonadism patients as well as 4 (36.4%) idiopathic
patients showed abnormal levels of the hormone (χ2
(corrected)= =35.512 and P=0.000).
Table-I
Testosterone and gonadotropins levels of the study population
Hormone Patients Controls % t P-
(n=74) (n=44) Difference value
Testosterone (ng/ml) 1.7±1.3 5.0±2.2 98.5 10.054 0.000
Range (min-max) (0.03-6.1) (1.9-11.7)
*LH (mIU/ml) 12.8±9.7 6.3±3.1 68.1 4.352 0.000
Range (min-max) (0.1-31.2) (1.1-11.8)
**FSH (mIU/ml) 20.8±14.8 7.7±3.9 91.9 5.708 0.000
Range (min-max) (0.1-48.0) (2.5-16.1)
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone. Reference values: Testosterone 2.0-7.0 ng/ml, LH 2.0-
13.0 mIU/ml, FSH 2.5-10.0 mIU/ml. All values are expressed as mean±SD. P<0.05: Significant.
Table-II
Testosterone and gonadotropins levels of different aspects of Sertoli cell only patients
1ry TF Hyper Hypo Idiopathy P-
Hormone (n=40) hypo hypo (n=11) F value
(n=9) (n=14)
Testosterone (ng/ml) 2.2±1.3 0.9±0.5 0.5±0.4 2.4±1.0 12.135 0.000
*LH (mIU/ml) 17.3±6.1 24.5±2.6 0.6±0.4 2.6±1.5 79.794 0.000
**FSH (mIU/ml) 28.9±6.3 37.4±6.7 0.6±0.5 3.5±1.6 167.415 0.000
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone, 1ry TF: Primary testicular failure, Hyper hypo: Hypergonadotrophic
hypogonadism, Hypo hypo: Hypogonadotrophic hypogonadism. Reference values: Testosterone 2.0-7.0 ng/ml, Lutenizing hormone 2.0-
13.0 mlU/ml, Follicle stimulating hormone 2.5-10.0 mlU/ml. All values expressed as mean±SD, P<0.05: Significant.
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Discussion
Male infertility is a reproductive health problem that is poorly
studied and understood. Worldwide, male infertility
contributes to more than half of all cases of childlessness
and it is argued that male infertility may be particularly
problematic for Middle Eastern men in their societies; there,
both virility and fertility are typically tied to manhood. Thus,
male infertility is a potentially emasculating condition,
surrounded by secrecy and stigma.13,14 In this context, there
are under-reporting or even no real figures on male infertility
in Gaza Strip. Therefore, the present study targeted Sertoli
cell only syndrome as one of the etiologies of azoospermia
focusing on testosterone and gonadotropins in infertile men
from Gaza Strip.
The mean age of the patients in the present study (29.8 years)
was lower than that reported from Nigerian (35.7 years) and
Kenyan (36.1 years) studies.15,16 The younger age of our
patient sample could be explained on the basis that most
men seeking out to have children at young age immediately
after marriage. Medical history showed that varicocele was
significantly more prevalent among patients compared to
controls. This coincides with the idea that varicocele
contributes to male infertility.17,18 The proposed
pathophysiologic mechanisms by which varicocele impairs
male fertility may include hypoxia and stasis, elevated
testicular temperature, reflux of adrenal catecholamines, and
increased oxidative stress.19 Hormonal problems were also
significantly higher in patients than controls implying that
Sertoli cell only syndrome is associated with hormonal
disturbances.20
Hormonal profile of the study population showed that the
mean level of testosterone was significantly lower in patients
compared to controls. Such decline in testosterone levels in
patients may be explained on the basis of hypogonadism
which is characterized by a deficiency or absence of Leydig
cell function in production of testosterone.21,22 In contrast,
the mean levels of LH and FSH were significantly elevated
in patients compared to controls. Such result is in accordance
with other studies.16,23 In the infertile men, higher
concentration of FSH is considered to be a reliable indicator
of germinal epithelial damage, and was shown to be
associated with azoospermia and severe oligozoospermia.24
The clinical picture of Sertoli cell only syndrome aspects in
infertile men in Gaza Strip showed marked lower levels of
testosterone in hypergonadotrophic hypogonadism and
hypogonadotrophic hypogonadism compared to the normal
reference value. Similar results were previously reported.25,26
Higher levels of LH and FSH were recorded in primary
testicular failure and hypergonadotrophic hypogonadism
whereas their levels were obviously lower in
hypogonadotrophic hypogonadism compared to the
reference values. Male hypergonadotropic hypogonadism is
characterized by hypogonadism due to an impaired response
of the testes to LH and FSH, and in turn a lack of testosterone
production and elevated gonadotropin levels as an attempt
of compensation by the body.21,27 In male hypogonadotropic
Table-III
Normal and abnormal testosterone and gonadotropins levels of different aspects of Sertoli cell only patients in Gaza Strip
Hyper Hypo
Hormone 1ry TF hypo hypo Idiopathic c2 P-
(n=40) (n=9) (n=14) (n=11) value
Testosterone (ng/ml) No. (%) No. (%) No. (%) No. (%)
Normal 22 (55.0) 0 (0.0) 0 (0.0) 8 (72.7) 18.890 0.000
Abnormal 18 (45.0) 9 (100) 14 (100) 3 (27.3)
*LH (mlU/ml)
Normal 10 (25.0) 0 (0.0) 0 (0.0) 7 (63.6) 12.644 0.005
Abnormal 30 (75.0) 9 (100) 14 (100) 4 (36.4)
**FSH (mlU/ml)
Normal 0 (0.0) 0 (0.0) 0 (0.0) 7 (63.6) 35.512 0.000
Abnormal 40 (100) 9 (100) 14 (100) 4 (36.4)
*LH: Luteinizing hormone, **FSH: Follicle stimulating hormone, 1ry TF: Primary testicular failure, Hyper hypo: Hypergonadotrophic
hypogonadism, Hypo hypo: Hypogonadotrophic hypogonadism; Reference values: Testosterone 2.0-7.0 ng/ml, Lutenizing hormone 2.0-
13.0 mlU/ml, Follicle stimulating hormone 2.5-10.0 mlU/ml. P-value of c2 (corrected) test, P<0.05: Significant.
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hypogonadism there is inadequate secretion of hypothalamic
gonadotropin releasing hormone and lack of production of
pituitary gonadotropins and in turn lack of
testosterone production.22,28
As depicted from data presented in this study, all infertile
men with hypergonadotrophic hypogonadism and
hypogonadotrophic hypogonadism showed abnormal levels
of testosterone, LH and FSH in comparison with their normal
reference values. Such findings supported the above
mentioned results that abnormal low levels of testosterone
were recorded in both hypergonadotrophic hypogonadism
and hypogonadotrophic hypogonadism as well as high and
low abnormal levels of LH and FSH were found in
hypergonadotrophic hypogonadism and hypogonadotrophic
hypogonadism respectively, and coincided with that
previously reported.16,29
Conclusion
Serum testosterone was significantly lower in patients than
controls, whereas LH and FSH were significantly higher in
patients. Abnormal lower levels of testosterone were found
in hypergonadotrophic hypogonadism and hypogo-
nadotrophic hypogonadism compared to the normal
reference value. Higher levels of LH and FSH were recorded
in hypergonadotrophic hypogonadism, whereas LH and FSH
levels were lower in hypogonadotrophic hypogonadism
compared to the reference values.
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